Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

RecruitingOBSERVATIONAL
Enrollment

845

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2029

Conditions
Unresectable Hepatocellular Carcinoma (HCC)Liver Metastases From Colorectal Cancer (mCRC)
Interventions
DEVICE

SIRT

Selective internal radiation therapy with SIR-Spheres Y90 resin microspheres.

Trial Locations (9)

28009

NOT_YET_RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

28220

NOT_YET_RECRUITING

Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda

46010

NOT_YET_RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

69495

RECRUITING

Hospices Civils de Lyon HCL Centre Hospitalier Lyon-Sud, Pierre-Bénite

92118

RECRUITING

Hôpital Beaujon, Clichy

94000

NOT_YET_RECRUITING

Hopital Henri Mondor, Créteil

M20 4BX

NOT_YET_RECRUITING

The Christie Hospital, Manchester

SE5 9RS

NOT_YET_RECRUITING

Kings College Hospital, London

W12 OHS

NOT_YET_RECRUITING

Hammersmith Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sirtex Medical

INDUSTRY